Skip to main content
logo
Kalaris Therapeutics, Inc. (KLRS)
NASDAQ: KLRS · Real-Time Price · USD
4.180
+0.095 (2.33%)
At close: Jun 10, 2026, 4:00 PM EDT
4.160
-0.020 (-0.48%)
After-hours: Jun 10, 2026, 4:10 PM EDT

Kalaris Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-44.1-43.44-69.17-190.42-168.71-171.96
Depreciation & Amortization
0.020.01-0.40.720.19
Stock-Based Compensation
2.141.940.940.7841.3243.98
Other Adjustments
-0.45-0.3149.7322.770.772.13
Change in Receivables
----0.05-0.110.4
Changes in Accounts Payable
-1.4-0.09-1.03-2.51-12.6220.29
Changes in Accrued Expenses
1.742.140.12---
Changes in Income Taxes Payable
----0.13-0.881.01
Changes in Other Operating Activities
-0.941.37-1.214.71-2.54-2.34
Operating Cash Flow
-42.51-38.37-20.67-124.45-142.05-106.32
Capital Expenditures
-0.02-0.2----0.03
Purchases of Investments
-70.35-34.52--125.83-228.81-76.59
Proceeds from Sale of Investments
2015-163.81148.33262.6
Investing Cash Flow
-50.35-19.72-37.99-80.48185.98
Issuance of Common Stock
0.0750070.5126.960.23
Net Common Stock Issued (Repurchased)
0.0750070.5126.960.23
Issuance of Preferred Stock
--1.59---
Net Preferred Stock Issued (Repurchased)
--1.59---
Other Financing Activities
-2.36105.0117.55---
Financing Cash Flow
46.05155.0119.1470.5126.960.23
Effect of Exchange Rate Changes on Cash and Cash Equivalents
------0.04
Net Cash Flow
-63.6396.91-1.53-15.97-95.5779.85
Free Cash Flow
-42.53-38.57-20.67-124.45-142.05-106.35
Free Cash Flow Per Share
-2.11-2.53-1.35-27.51-42.62-38.96
Levered Free Cash Flow
-44.7-40.2-71.29-187.95-184.03-152.85
Unlevered Free Cash Flow
-48.23-42.91-53.86-197.3-186.25-151.7
SEC Filings: 10-K · 10-Q